5-11岁儿童COVID-19疫苗提供者可及性与接种覆盖率——美国,2021年11月至2022年1月
2021年10月29日辉瑞-BioNTech儿童COVID-19疫苗获美国紧急使用授权用于5-11岁儿童。截至2021年11月29日(启动后4周)有38,732家提供者入组,92%的5-11岁儿童居住在距活跃提供者5英里内。启动后4周首剂覆盖率为15.0%(高SVI地区10.5% vs 低SVI地区17.5%,率比[RR]=0.68;95%CI=0.60-0.78),11周为27.7%(高SVI地区21.2% vs 低SVI地区29.0%,RR=0.76;95%CI=0.68-0.84)。11周全程完成率为19.1%(高SVI地区13.7% vs 低SVI地区21.7%,RR=0.67;95%CI=0.58-0.77)。药房接种了该年龄组46.4%的剂次,其中高SVI地区48.7%、低SVI地区44.4%。尽管接种覆盖率较低,尤其在高SVI地区,但首剂覆盖率随时间改善。
要点
- 截至2021年11月29日,38,732家提供者入组,92%的5-11岁儿童居住在距活跃提供者5英里内。
- 启动后11周首剂覆盖率27.7%,高SVI地区21.2% vs 低SVI地区29.0%(RR=0.76;95%CI=0.68-0.84)。
- 药房接种了该年龄组46.4%的剂次,高SVI地区48.7%,低SVI地区44.4%。
核心结论
- 尽管COVID-19疫苗接种覆盖率较低,尤其在高SVI地区,但首剂覆盖率随时间改善。
- 需要额外 outreach,尤其在高SVI地区,以提高疫苗信心并增加5-11岁儿童的接种覆盖率。
研究设计与样本
- 2021年11月1日至2022年1月18日期间,检查高和低SVI社区5-11岁儿童的COVID-19提供者可及性和早期接种覆盖率。
- 2021年10月29日辉瑞-BioNTech儿童COVID-19疫苗获美国紧急使用授权用于5-11岁儿童。
主要发现
- 截至2021年11月29日(启动后4周),38,732家提供者入组,92%的美国5-11岁儿童居住在距活跃提供者5英里内。
- 启动后4周首剂覆盖率为15.0%(高SVI地区10.5% vs 低SVI地区17.5%;RR=0.68;95%CI=0.60-0.78)。
- 启动后11周首剂覆盖率为27.7%(高SVI地区21.2% vs 低SVI地区29.0%;RR=0.76;95%CI=0.68-0.84)。
- 启动后11周全程完成率为19.1%(高SVI地区13.7% vs 低SVI地区21.7%;RR=0.67;95%CI=0.58-0.77)。
临床怎么用
- 需要额外 outreach,尤其在高SVI地区,以提高疫苗信心并增加5-11岁儿童的接种覆盖率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
On October 29, 2021, the Pfizer-BioNTech pediatric COVID-19 vaccine received Emergency Use Authorization for children aged 5-11 years in the United States.† For a successful immunization program, both access to and uptake of the vaccine are needed. Fifteen million doses were initially made available to pediatric providers to ensure the broadest possible access for the estimated 28 million eligible children aged 5-11 years, especially those in high social vulnerability index (SVI)§ communities. Initial supply was strategically distributed to maximize vaccination opportunities for U.S. children aged 5-11 years. COVID-19 vaccination coverage among persons aged 12-17 years has lagged (1), and vaccine confidence has been identified as a concern among parents and caregivers (2). Therefore, COVID-19 provider access and early vaccination coverage among children aged 5-11 years in high and low SVI communities were examined during November 1, 2021-January 18, 2022. As of November 29, 2021 (4 weeks after program launch), 38,732 providers were enrolled, and 92% of U.S. children aged 5-11 years lived within 5 miles of an active provider. As of January 18, 2022 (11 weeks after program launch), 39,786 providers had administered 13.3 million doses. First dose coverage at 4 weeks after launch was 15.0% (10.5% and 17.5% in high and low SVI areas, respectively; rate ratio [RR] = 0.68; 95% CI = 0.60-0.78), and at 11 weeks was 27.7% (21.2% and 29.0% in high and low SVI areas, respectively; RR = 0.76; 95% CI = 0.68-0.84). Overall series completion at 11 weeks after launch was 19.1% (13.7% and 21.7% in high and low SVI areas, respectively; RR = 0.67; 95% CI = 0.58-0.77). Pharmacies administered 46.4% of doses to this age group, including 48.7% of doses in high SVI areas and 44.4% in low SVI areas. Although COVID-19 vaccination coverage rates were low, particularly in high SVI areas, first dose coverage improved over time. Additional outreach is critical, especially in high SVI areas, to improve vaccine confidence and increase coverage rates among children aged 5-11 years.
引用
- Kim C, Yee R, Bhatkoti R, et al. COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35271559. doi:10.15585/mmwr.mm7110a4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。